cGxP.wire https://validator.w3.org/feed/docs/rss2.html Aligos Therapeutics Gains Fast Track for HBV Drug Radical Catheter Gains FDA Clearance for 6F Device Telix Doses First Patient in Phase 3 Glioblastoma Trial Clarity Signs Deal to Boost Prostate Cancer Imaging Supply XellSmart Advances Phase 2 Parkinson’s Cell Therapy Trial Boehringer Introduces LENZELTA Vaccine for Mastitis Control TOBY Gains FDA Breakthrough Status for MCED Test Mabwell Advances SST001 PET Tracer to Phase I Trial Partner Therapeutics Files sBLA for BIZENGRI in CCA Apotex Secures FDA Approval for Generic Infuvite Injection Protaryx Wins FDA 510(k) Clearance for Cardiac Device Avanos to Be Acquired by AIP in $1.27B Deal GlycoNex Secures PMDA Nod for GNX1021 Phase 1 Trial Revolution Medicines Reports Phase 3 Survival Gain PDAC Neurocrine Shows INGREZZA Persistence Edge in TD Study SynOx Phase 3 Study Shows TGCT Treatment Benefit BioOra and Cincinnati Advance CAR-T Therapy in Leukemia Penumbra Shows Strong Outcomes in STORM-PE Study Akebia Therapeutics Doses First in AKB-9090 Trial Endpoint Clinical Launches Elosity R3 AI Trial Platform Travere Therapeutics Wins FDA Approval for FILSPARI in FSGS Septerna Initiates SEP-479 Phase 1 Hypoparathyroidism Personalis Advances ctDNA Cancer Monitoring with AI Platform Sirtex Medical Reports 100% Tumor Control in DOORwaY90 GSK Reports Strong ADC Data in Ovarian Cancer Study Enanta Pharma Advances EDP-978 Phase 1 Urticaria Drug Telix and Regeneron Partner to Advance Radiopharma Therapies Ocular Therapeutix AXPAXLI Shows Strong Phase 3 AMD Vivatides Therapeutics Raises $54M to Expand RNA Therapies NeoGenomics Advances AI-Driven Oncology Insights at AACR Eli Lilly Reports Breakthrough Phase 3 Jaypirca Results Daiichi Sankyo Secures FDA Priority Review for ADC Therapy Allogene Therapeutics Reports Strong ALPHA3 Trial Data Novo Nordisk Secures EMA Approval for Wegovy Delivery Flexibility ANI Pharma Launches Carbamazepine ER Capsules in US Nxera Pharma Advances Schizophrenia Drug to Phase 2 Regeneron Dupixent EU Approval Expands Pediatric CSU Care Roche Gets CE Mark for Elecsys NfL MS Blood Test AnBogen Therapeutics Showcases ABT-301 Cancer Breakthroughs AbbVie Reports Strong Phase 2 Data in Ovarian Cancer Spyre to Reveal SKYLINE UC Trial Results on April 13 Replimune RP1 Melanoma Drug Faces FDA Rejection Allogene to Reveal ALPHA3 CAR-T Trial Data Soon IDEAYA to Reveal Phase 3 Melanoma Trial Results Soon Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers Telix NDA Accepted for Pixclara Brain Cancer Imaging Johnson & Johnson Showcases TECNIS PureSee IOL Data Insilico Medicine Advances ISM6200 for Cancer Therapy Lupin Launches Dapagliflozin Tablets in U.S. Market FibroBiologics Advances Thymus Organoid Cancer Therapy